EP1171053A2 - Procede et appareil permettant de traiter les caries dentaires - Google Patents

Procede et appareil permettant de traiter les caries dentaires

Info

Publication number
EP1171053A2
EP1171053A2 EP00925455A EP00925455A EP1171053A2 EP 1171053 A2 EP1171053 A2 EP 1171053A2 EP 00925455 A EP00925455 A EP 00925455A EP 00925455 A EP00925455 A EP 00925455A EP 1171053 A2 EP1171053 A2 EP 1171053A2
Authority
EP
European Patent Office
Prior art keywords
photosensitiser
lesion
hght
cavity
fibre
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP00925455A
Other languages
German (de)
English (en)
Other versions
EP1171053B1 (fr
Inventor
David Corbett Hamilton
Michael John Colles
Jill Ann Williams
Gavin John Pearson
David John Clements
Michael Eastman Dental Institute WILSON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denfotex Ltd
Original Assignee
Denfotex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9908824.7A external-priority patent/GB9908824D0/en
Priority claimed from GB0000884A external-priority patent/GB0000884D0/en
Priority claimed from GB0000886A external-priority patent/GB0000886D0/en
Application filed by Denfotex Ltd filed Critical Denfotex Ltd
Publication of EP1171053A2 publication Critical patent/EP1171053A2/fr
Application granted granted Critical
Publication of EP1171053B1 publication Critical patent/EP1171053B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C5/00—Filling or capping teeth
    • A61C5/30—Securing inlays, onlays or crowns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/65—Dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N5/0603—Apparatus for use inside the body for treatment of body cavities
    • A61N2005/0606—Mouth

Definitions

  • This invention relates to a method and apparatus for treating dental caries.
  • the method involves killing within or on a tooth bacteria associated with dental caries and then sealing the treated area to prevent re-infection.
  • Preventive dentistry killing bacteria in fissures and on the surface of the tooth prior to sealing and also on the surface of enamel and dentine prior to restoration placement.
  • Dental caries is a chronic invasive disease, which can lead to irreparable destruction of tooth tissue.
  • the lesion is created by acid producing bacteria in the plaque. These metabolise carbohydrates and sugars in the plaque and produce acid.
  • the lesion develops first by a demineralisation process of the enamel, the outer covering of the crown of the tooth. The demineralisation produces the porous surfaces, which will eventually permit of migration of bacteria though tubules into the dentine.
  • Enamel is acellular and once destroyed may not be replaced. Once the advancing demineralisation front reaches the enamel dentine junction, it spreads laterally along the enamel dentine junction leading to further demineralisation on a broad front.
  • the structure of the dentine differs from enamel having an organic matrix, which is calcified. Cell processes run through the dentine initially in the young from pulp to enamel dentine junction. With age this structure becomes more calcified from the outer surface of the dentine inwards.
  • the dentine is first demineralised, and then this is followed by a phase where the bacteria colonise the denatured dentine.
  • the dentine tubules become dilated and the bacteria can then lie within the lumen of the tubules. They receive nutrients through simple diffusion processes from the outer surface of the enamel. It has been well established that the bacteria, which are anaerobic, will become dormant or die if the supply of nutrient is cut off.
  • Dental amalgam has proved to be the material of choice for the last one hundred years but its use is now being questioned both on environmental, safety and aesthetic grounds. It is however the material which most practitioners find the easiest to use.
  • Dental composites overcome the problem of aesthetics and can withstand moderate degrees of wear but their shrinkage on setting and their demanding technique and technique sensitivity have meant that their time of placement is about one and half that of a dental amalgam. They also require the use of a dentine adhesive to reduce the marginal leakage. These are again technique sensitive.
  • Glass polyalkenoate cements while being therapeutic because of their fluoride release and uptake, are brittle materials and as y + none of the materials available are suitable for universal use in the oral cavity.
  • a primary object of the present invention is to provide a technique for minimally invasive treatment of dental caries with the minimal removal of tooth tissue, in contrast to current practice.
  • this technique involves the preparation of a small tunnel from the outer surface of the tooth to the site of the carious lesion. The access may be made using a very fine round bur in a high-speed dental handpiece. This will permit the removal of enamel and dentine to produce a narrow tunnel about 400 to 1000 microns, preferably 500 to 800, e.g. about 600 microns in diameter.
  • a laser-cutting device may be used to cut the tunnel.
  • the carious dentine will be inoculated with a light photosensitising compound, e.g. a sensitive dye.
  • a light photosensitising compound e.g. a sensitive dye.
  • suitable photosensitisers are given in European Patent No. 0637976.
  • the bacteria will take up the dye or other photosensitiser and once sensitised, the lesion will be irradiated with light of a specific wavelength. The interaction between the laser and the dye leads to singlet oxygen release and results in the death of the bacteria and this is the basis of photodynamic therapy.
  • the lesion & the demineralised dentine surrounding it will be infiltrated with a dentine substitute which will be polymerised in situ.
  • Fluoride can be included in this resin composition to provide a therapeutic effect after the photodynamic therapy (PDT) has been completed.
  • a method of treating dental caries which comprises the steps of:-
  • the treatment of the carious lesions in accordance with the invention involves removing the minimum of tooth material, access to the lesions is established by cutting cavities of narrow diameter.
  • Activation of the photosensitiser within the cavity is achieved by using an optical fibre having a small diameter and tip which is less than 1 mm and preferably about 800 microns or less.
  • the tip may have a maximum lateral dimension of 400 microns or less, e.g. about 200 microns.
  • carious lesions which are advantageously treated in accordance with the invention. These include accessing the lesion by drilling an access tunnel from the tooth surface to a lesion located beneath the crown.
  • the invention is also applicable to the treatment of root caries, sure sealing, in advanced restorative work and in treating recurrent caries beneath a restoration or artificial crown.
  • the invention includes according to another aspect use in the manufacture of materials for sterilising and sealing a carious lesion, which has been exposed by mechanical removal of diseased dentine to form a cavity, of a kit of parts comprising:-
  • an optical fibre which is shaped and dimensioned to enter the cavity, said fibre being connectable proximally to means for generating laser light at a wavelength which is capable of being absorbed by the photosensitiser, and said fibre having a distal portion which is free from an internally light-reflecting layer and is shaped to spread light substantially isotropically and, preferably, uniformly around the cavity;
  • the invention also includes use in the manufacture of materials for treating root caries at the cervical margin of the crown and the root face of a kit of parts comprising:-
  • an optical fibre which is connectible proximally to means for generating laser light at a wavelength which is capable of being absorbed by the photosensitiser and which has a distal tip which is free from an internally reflecting layer and is shaped to spread light around an arc of up to 360°, the fibre being associated with a reflecting surface for reflecting light back at said cervical margin, and
  • a further aspect of the invention is the use in the manufacture of materials for a preliminary treatment prior to fissure sealing of a kit of parts comprising:- (a) a flowable photosensitiser;
  • an optical fibre which is connectable proximally to means for generating laser hght at a wavelength capable of being absorbed by the photosensitiser and which has a substantially isotropic distal tip which is free from an internally reflecting layer, the tip being shaped and dimensioned so that it can be drawn along the fissure system to activate the photosensitiser;
  • the invention further includes the use in the manufacture of materials for the treatment of recurrent caries beneath a restoration which has been exposed by cutting a tunnel cavity from the surface of the tooth the carious site, of a kit of parts comprising :-
  • an optical fibre which is shaped and dimensioned to enter the cavity, said fibre being connectable proximally to means for generating laser light at a wavelength which is capable of being absorbed by the photosensitiser, and said fibre having a distal portion which is free from an internally light-reflecting layer and is shaped to spread light around the cavity;
  • the bacteria associated with dental caries can be killed using a photosensitiser and an activation system.
  • concentration of the light sensitive dye or other photosensitiser and the sensitisation time are well within the clinical requirements of the practising dentist
  • sealant compositions which are of low viscosity and are capable of flowing into narrow cavities and fissures.
  • sealing compositions comprise mixtures of tetrahydrofurfuryl methacrylate (THFMA) (or a derivative thereof), with one or more mono and difunctional acrylates and/or methacrylates.
  • THFMA tetrahydrofurfuryl methacrylate
  • the sealant composition should be fluid enough when syringed into the cavity or recess after the photosensitisation treatment.
  • a typical cavity may have a diameter of about 500 to 1000 microns.
  • Typical viscosities are 0.6 to 1350 centipoise.
  • Preferred sealant compositions comprise a mixture of at least one resin containing on average at least two acrylate or methacrylate groups and a copolymerisable methacrylate or acrylate monomer which has a low viscosity compared with the resin.
  • the methacrylate monomer is a heterocyclic dimethacrylate, e.g. TFfFMA.
  • the resin is preferably a urethane dimethacrylate or a glycidyl dimethacrylate, such as an epoxy dimethacrylate.
  • Such compositions are described in more detail in our co-pending British patent application No. 0000886.2 (Our ref: DFX Case C) filed concurrently herewith.
  • the agent After introducing the photosensitising agent into the narrow bore hole in the tooth, the agent is activated using hght delivered by an optical fibre from a laser at an appropriate wavelength which is absorbed strongly by the photosensitiser.
  • the wavelength employed depends on the absorption spectra of the photosensitiser.
  • Toluidine blue O ortho-toluidine
  • Semiconductor lasers, gaUium/arsenide and helium/neon lasers may be used.
  • the laser light may be continuous or pulsed.
  • the light is pulsed, preferably there is a short interval between the pulses, e.g. a fraction of a second to one second, preferably about X second. It has been found to be important to spread the laser light uniformly within the bore hole rather than focus it on a small target area.
  • One way of achieving this is to provide an optical fibre which terminates in an isotropic tip, e.g. a generally spherical tip. A method of forming such a tip is described in US Patent No. 5,073,402.
  • the light-spreading distal tip may be conveniently formed by moulding or casting a curable light transmissive composition on the end of the optical fibre.
  • a spherical tip may be formed by dipping the optical fibre into a polymerisable composition and curing the adherent droplet, while supporting the droplet in a non- miscible liquid. Curing may be effected by passing hght of the appropriate wavelengths for curing along the optical fibre.
  • Suitable polymerisable compositions include hght curable acrylate and methacrylate compositions, including those described below as suitable sealant materials. It may be desirable to include a light-scattering material within the polymerisable material to increase the viniformity of irradiation of the root canal. However, the cured tip will be transparent or translucent to hght of the wavelength selected for sensitising the dye.
  • shaped tips maybe formed by moulding or casting the desired shape onto the end of the optical fibre.
  • An isotropic light-emitting tip may also be formed by removing the internally reflective outer layer of the optical fibre over a short distance from the distal end, or by restricting the outer layer so that it is not applied to the distal end.
  • the photosensitising agent may be delivered in a unidose system.
  • the dentine substitute will act in a similar way to the currently available dentine adhesives which set out to infiltrate dentine which has been partly demineralised using acid demineralising agents.
  • the dentine substitute will infiltrate the demineralised dentine and provide an hermetic seal.
  • a secondary role is the strengthening of this layer producing a dentine type substitute which has properties akin to dentine and which will support a small restoration sealing the access cavity.
  • the photosensitising compound is used for the disinfection of the tooth surface and internal structure by placement using a hquid or gel or varnish in contact with the lesion and irradiating the tissue with hght of an appropriate wavelength that will be absorbed by the photosensitiser.
  • the hquid, gel or varnish are generally aqueous.
  • a gel may be formed by including a gelling agent in the aqueous solution of the photosensitiser. Suitable gelling agents include hydrophiUc polymers such as cellulose derivatives and polyvinyl pyrrolidone.
  • thickening agents such as colloidal silica (e.g. Cabasil) may be added, e.g. in amounts of up to 10% by weight. Gels are particularly useful in pre-treatment prior to fissure sealing or where the cavity is shallow.
  • the photosensitiser and laser combination may be applied to
  • Photosensitising agents used in this invention are generally non-toxic to the target microbes in the concentrations envisaged and particularly to the surrounding tissue. However there is no requirement that the photosensitiser should not be toxic to the microbes. Since the exposure time are short it may be acceptable to use compounds which have some slight toxicity to the tissue.
  • the photosensitisers used will be capable of absorption in the red end of the visible spectrum or at longer wavelength as these wavelengths will have greater penetrating powers in the tissue surrounding the lesion.
  • the preferred photoinitiators are those effective against Gram Negative ba c teria associated with dental caries. These are the dyes. Of these the currently preferred is toluidine blue O. Alternatively aluminium disulphonated phthalocyanine chloride, methylene blue, azure blue chloride may be used. While the dye may be non specific it can be made specific to the microbes within the carious lesion.
  • the concentration of photo-initiator and laser power are matched to provide maximum penetration of tissue and kill rates
  • the concentrations of dye range from 0.00001% to 0.1%.
  • the preferred concentration is 0.001 to 0.01%.
  • the preferred laser irradiation time of the photosensitiser is between 10 seconds and 90 seconds and the preferred exposure time is 20 to 60 seconds, especially 20 to 40 seconds.
  • the laser power is preferably between 20 and 60Q mW, e.g. 40 to 200 mW, the most preferred being 40 to 150 mW.
  • the photosensitiser solution concentration may be influenced by any extrinsic fluid and concentration may increased to compensate for this.
  • the agent may be used in conjunction with, prior to or subsequent to, the photosensitising solution.
  • Photosensitising solution may be:
  • Demineralising agents such as chelating agents of the type EDTA disodium.
  • Such materials may be citric acid, polyalkenoic and poryphosphonic acid, phosphoric acid, EDTA and HEMA or other such acids as are known for use in this technique.
  • EDTA and citric acid have an adverse effect on the bacterial kill rate if used simultaneously with the photosensitising treatment.
  • these additives should be used prior to or after treatment with the photosensitiser and the treated area flushed with a wash hquid prior to treatment with the photosensitiser.
  • Phosphoric acid particularly when buffered to a pH of 4.5 or above appears to have a beneficial effect on bacterial kill rates when used at the same time as the photosensitisation treatment.
  • a further addition to the photosensitising phase is the addition of remineralising solution to be applied with or subsequent to the application of the dye.
  • Suitable agents are described by Causton BE and Newell Johnson NW, 1982, BDJ: 152, 9-11, Levine RS, Beech DR and Garton B, 1977, BDJ, 143, 275-277 or Pearse and Nelson Caries Research 1988 22,362-370.
  • the photosensitiser may be delivered by a syringe, for example, by a unit dose device through which the fibre optic probe may be passed, e.g. as described below.
  • the bore hole in the tooth is sealed by introducing a resin as a Dentine Substitute which will infiltrate the remaining dentine structure infilling the porous structure.
  • the resin filling material can be a syringeable resin with low viscosity which may be polymerised using hght or by auto- polymerisation. Additionally the resin may release fluoride. If the resin is light- polymerised, hght of a suitable wavelength to cure the resin can be conducted into the hole using the same optical fibre.
  • the purpose of the sealant is to exclude air from the treated area, e.g. cavity or recess.
  • Possible resins which may be used to seal the hole in the tooth include:-
  • the hermetic seal after bacterial lolling is an integral part of the non invasive technique since it is by these means that the bacterial re-infection is rninimised. This may be achieved using existing dental materials.
  • the preferred materials may have a viscosity, which may be varied to suit the application.
  • Preferred viscosities are from 0.33 to 1340 centipoise.
  • the viscosity is similar to that of water and has mechanical properties such as flexural strength after polymerisation in the range 80 to 170 Mpa. Shrinkage during polymerisation will be in the range of 0.5 to 4.5% by volume.
  • the dentine substitute is made of a blend of resins, which will provide a range of viscosities to suit the intended application.
  • the preferred formulation is a mixture of urethane dimethacrylate (UDMA), bisphenol-A-glycidyl dimethacrylate (BisGMA) and tetrahydrofurfuryl methacrylate (THFMA). These may be in various proportions, the preferred composition being THFMA 50% UDMA 33% and BisGMA 17%.
  • UDMA urethane dimethacrylate
  • BisGMA bisphenol-A-glycidyl dimethacrylate
  • THFMA tetrahydrofurfuryl methacrylate
  • the material may be polymerised chemically or by the application of hght of a particular wavelength.
  • Sealant materials based on light-curable acrylates or methacrylates are commonly cured with hght having a wavelength of about 450- 470nm.
  • Cold cure initiator systems which do not require the addition of external energy (heat or hght) are materials such as benzoyl peroxide as an initiator and N,N-dimethyl- p-toluidine as an activator.
  • Preferred hght activation systems are those including camphorquinone and an amine. Other activation systems may also be used.
  • the initiators should be present in an appropriate amount to provide an adequate level of conversion and adequate rate of conversion. They are usually present in amounts between 0.1% and 12% of the weight of the monomer mixture. Preferred values are between 0.5 and 5% by weight of the monomer mixture.
  • additives may optionally be included in the mixture such as antioxidants, stabilisers using UV inhibitors and polymerisation inhibitors, pigments and therapeutic agents such as antibiotics, corticosteroids and other medicinal agents such as metal ions.
  • TABLF 1 Toluidene blue O
  • Dye solutions were made up freshly on each occasion using distilled water. Initially, 100 ⁇ l of a saline suspension of Streptococcus mutans was added to a micro well of a microtitre plate. These were derived from Streptococcus mutans NCTC 10449 and suspension was made up to give a concentration of bacteria ranging between IO 8 to IO 9 colony forming units (cfu). [These had an optical density of approximately 0.10]. This solution was then gently agitated for the remainder of the experiment. To this was added either lOO ⁇ l of TBO or saline. Saline acted as a control. 30 seconds a ft er the addition of the dye, the isotropic probe was immersed in suspension and irradiation carried out at the range of exposure time/power density combinations indicated in Table 1.
  • Aluminium foil was wrapped around the base of each well on the microtitre plate to prevent laser irradiation affecting wells adjacent to that being treated.
  • the number of survivors in each well was determined by viable counting on tryptone soya agar. lOO ⁇ l of hquid from the micro well was removed and diluted progressively tenfold. The diluted suspension was then cultured on the tryptone soya agar plate for 24 hours. Plates were then selected with densities of colony forming units of between 50 - 300 cfu and these were examined for surviving bacteria over the whole of the sample on the plate.
  • a range of kill * levels was achieved with the different combinations of laser power exposure time and dye concentration. This shows that the kill levels required may be achieved at certain laser power/exposure time/dye concentrations. There is a range of combinations, which may be appropriate for use clinically.
  • the laser parameters were defined by the outputs of the machine and 80 and 15mw selected as the outer limits for initial evaluation.
  • Dye concentrations were fixed at values that had previously been established for penetration of dentine.
  • Stage 1 Maximum dye concentration and Maximum laser power
  • Stage 2 Minimum dye concentration and Minimum laser power
  • Exposure Time 20 sec
  • the exposure time of 20 seconds produced kill rates which were substantially higher. At the 20 ⁇ g/mL dye concentration tested here 80% kill levels were obtained.
  • the exposure time was extended to 50 seconds with a low dye concentration and low laser power.
  • the kill rates while not being total were extensive. This indicated that the lower dye concentration [5 ⁇ g ml] is probably the bottom level that is apphcable. It would require a high laser output and longer exposure time for total killing to be achieved.
  • Phase 2 Lethal photosensitisation of Strep mutans in a collagen matrix
  • This section of the study was designed to repeat phase 1 study using a collagen matrix to determine the effect of collagen on light/dye penetration using laser exposure times determined initially. The outcome was to demonstrate that in a collagen matrix kill rates of 10 8 to 10"° could be achieved.
  • the method is modified from that described previously in Caries Research [1995] 29:192-197.
  • the dye solution selected for use was an aqueous solution with a pH adjusted to 5. No additives were included in this study. Additives were not included at this stage as the work in bacterial suspension showed that additives were reducing the effectiveness of the PDT process. This is an area that will be evaluated further in the next phase.
  • the laser powers used were 80mW and 60 mW.
  • the collagen plug was treated with 50ml of 0.5mg/ml type 1A collagenase for three hours to hberate the survivors and enable the enumeration by viable counting as described above in stage 1.
  • the preliminary contact time of 60 minutes was used to evaluate the permeation of the dye through the dense collagen plug.
  • dye contact/dwell times of between 30 seconds and 3 minutes have been found to be satisfactory.
  • Laser irradiation times of between 30 and 180 seconds are generally preferred.
  • the photosensitiser may be maintained in contact with the lesion for an extended period, e.g. up to about 5 minutes or more, preferably 30 seconds to 3 minutes, before treatment with the laser.
  • the lesion may be flushed with a solution of the photosensitiser so that the bacteria is contacted with a stream of fresh photosensitised solution.
  • Figure 1 is a schematic cross-section through a tooth with an optical fibre in place in a hole drilled into a decayed internal portion of the tooth;
  • Figure 1 (a) is a plan view of the tooth shown in Figure 1 ;
  • Figure 2 is a sectional view on a larger scale showing an optical fibre and catheter for introducing a photosensitiser and sealing resin into the cavity;
  • Figure 2(a) is a schematic sectional view of a dental handpiece fitted with an optic fibre tip and a tube for introducing photosensitiser into the cavity;
  • Figure 3 is a perspective view of the laser housing connected to a dental handpiece
  • Figure 4 is a view in the direction of arrow X in Figure 3.
  • Figure 5 is a graph showing the effect on increasing the hght transmission of carious dentine by demineralisation with EDTA.
  • a tooth (1) is first drilled with a fine dental drill or with a laser to form a narrow tunnel (2) to a decayed area (3).
  • a flexible optical fibre (4) is introduced into the hole until the tip (5) is located close to the closed end of the tunnel.
  • the fibre is formed with a generally spherical transparent tip to ensure that hght passing down the fibre (4) and emerging at the tip is scattered generally uniformly around the cavity (3).
  • Photosensitiser comprising an aqueous solution of toluidine blue having a co ⁇ entration of 50 ⁇ g/ml, is injected into the tunnel, e.g. using a syringe.
  • the photosensitiser is activated by connecting the proximal end of the optical fibre to a laser source and the photosensitiser in the cavity (3) irradiated for 60 seconds at a laser power level of 60 mW and wavelength of 640 nm.
  • the interior of the cavity (3) was substantially completely sterilised by this treatment and the tunnel was then filled with a fluid, curable resin, e.g. using a syringe.
  • the composition employed was a mixture of tetrahydrofurfuryl methacrylate (THFMA), 50 weight percent, urethane dimethacrylate (UDMA) 33 weight percent and Bisphenol-A-glycidyl dimethacrylate (BisGMA) 17 weight percent.
  • This resin is light-curable and is most effectively cured at a wavelength of about 450 to 470 nm.
  • the resin may be cured by directing laser hght using an optical fibre having a hght spreading tip.
  • the hght may be generated by LED's centred at 470 nm or 150 or 200 mW with an exposure time of between 5 and 30 seconds.
  • optical fibre can be used to apply hght irradiation to the resin as for carrying out the sterilisation step. However, it is necessary to use a different laser source because of the different wavelengths employed.
  • the optical fibre may be cut off, e.g. with a rotary saw blade or simply snapped off and the upper surface smoothed over.
  • FIG. 2 shows a modification of the optical fibre which incorporates a catheter having reservoirs of photosensitiser and resin.
  • the optical fibre (4) is threaded through a catheter (6).
  • two reservoirs (7) and (8) are provided.
  • Reservoir (7) contains photosensitiser and reservoir (8) contains uncured resin.
  • the dentist compresses the reservoir (7), which ruptures a membrane (10) and allows photosensitiser to flow between the optical fibre and the catheter and out of the distal end of the catheter.
  • reservoir (8) is squeezed. This causes resin to flow through the gap between the optical fibre and the catheter and displace the photosensitiser to fill the tunnel.
  • the resin is then cured as described above and the optical fibre and catheter can then be cut off and the treated dental caries area sealed.
  • FIG 2(a) shows a developed form of the system shown in Figures 1 and 2.
  • the handpiece (42) has a 'plug in' optic fibre (4) having an isotropic tip (5).
  • the fibre is received as a snap fit in the handpiece (42) and is optically connected through the handpiece to a laser source in the console (41).
  • Surrounding the optic fibre is a hollow tube (6).
  • Contained within the handpiece are reservoirs (7) and (8) filled, respectively, with photosensitiser dye and sealant composition.
  • Feed tubes (9) and (10) connect the reservoirs to the tube (6).
  • the reservoirs may be squeezable pouches so that on applying pressure to the respective pouch, dye or fluid resin can be injected as required into the tube (6) and thence into the prepared cavity (2) or recess in the tooth.
  • the reservoirs, fibre tip and tube are disposable.
  • FIG. 3 shows a perspective view of the laser housing (41) linked to a dental handpiece (42).
  • An optical fibre (43) is held in the part of the handpiece which will be introduced into the patient's mouth.
  • the optical fibre (43) is a disposable "plug in” element which carries an isotropic tip as described above in relation to Figures 1 to 2.
  • Housing (41) contains laser generating equipment whose output is connected to a flexible heavy duty optical fibre within the handpiece, the output from the fibre (44) is connected to the disposable fibre (43).
  • Two laser sources may be accommodated in the housing (41), one capable of emitting laser hght at a wavelength of about 670 nm for effecting the photosensitising treatment, and the other capable of emitting laser hght for curing the resin sealant.
  • Light guides and a beam splitter may be provided so that hght from each laser source can be selectively switched to the tip (43).
  • the fibre tip may be changed after the photosensitising treatment has been carried out and a fresh tip plugged in to the handpiece in order to carry out curing of the resin sealant.
  • Figure 4 shows a control panel (45) having a touch screen (46) for programming the laser power and duration of treatment.
  • the apparatus can be made in portable form and incorporate a rechargeable battery.
  • PDT photodynamic therapy
  • PDT with or without the novel resin may be used in a conventional cavity.
  • the cavity may be prepared with burs and hand instruments in the conventional manner.
  • the solution of the dye which is left for a period of time between 20 and 90 seconds, the preferred range is between 20 and 40 seconds.
  • Excess dye solution is removed and the internal surfaces of the cavity exposed to hght of the appropriate wavelength to activate the sensitiser for a period of time.
  • the time of exposure will be between 20 and 90 seconds, and the preferred exposure time will be between 30 and 60 seconds.
  • the power densities will range between 40 and 600 mW, e.g. from 40 to 150 mW, the preferred range being 40 to 80 mW.
  • the dehvery system for the hght will consist of a fibre optic wand with preferably an isotropic emitter at the tip. This would provide a means of uniform radiation over the internal surface of the prepared cavity.
  • a preferred method of treatment to enhance access to bacteria remaining within the mineralised part of the tooth and to ensure the photosensitising agent achieved maximum effect, would be to use solutions which open up the dentinal tubules. These would be used prior to apphcation of the photosensitiser. Such solutions are those acids, demineralising agents and wetting agents as described above.
  • the cavity may be restored with conventional restorative agents or, alternatively, the novel resin may be used as a base. This may be achieved by first applying the resin solution and then applying the resin in its filled form, since this will provide a mouldable paste.
  • hght of an appropriate wavelength will be used to polymerise the resin after placement and provide a hermetic seal.
  • auto-polymerisation may be carried out.
  • the outer covering of the material may be with conventional restoratives.
  • PDT/Resin use in the treatment of caries where, the lesion is found at the cervical margin of the crown and on the root f ⁇ .ce.
  • the lesion is generally extensive but relatively shallow.
  • the lesion is initially treated with the photosensitiser. This may be in solution or gel form, and will be worked into the lesion using appropriate implements such as brushes or gel applicators.
  • the time of exposure will be within the range of 20 to 90 seconds.
  • the lesion is then exposed to hght of the appropriate wavelength for times ranging from 30 to 90 seconds.
  • the power densities used will be in the range of 40 to 600 mW, e.g. about 40 to 100 mW.
  • the isotropic tip may be passed through a strip with an internal reflective surface. This is adapted to the surface of the lesion and reflects hght back onto the lesion surface. This matrix will be of a similar shape and configuration to the tooth surface.
  • the uptake of dye by the lesion may again be enhanced by the use of solutions as described above.
  • a low viscosity resin will be painted over the surface and worked into the lesion.
  • hght of an appropriate wavelength will be used to polymerise the resin after placement and provide a hermetic seal.
  • auto-polymerisation may be carried out.
  • PDT may be used as an adjunct to conventional fissure sealing.
  • the fissures Prior to use of the conventional resin, the fissures are acid etched with 35% phosphoric acid for 15 to 30 seconds.
  • the photosensitiser is applied in solution form to the fissure system for a period of between 10 to 40 seconds. Excess solution is removed and the fissures irradiated with hght of a suitable wavelength using a fibre optic wand with an isotropic tip at the end. The isotropic tip is drawn along the fissure system.
  • the fissures are coated with fissure sealant which is then polymerised using a visible hght source of an appropriate wavelength.
  • the fibre optic dehvery tip is placed through this and the reflective surface, used in conjunction with the isotropic tip, provides a uniform irradiation over the preparation surface.
  • the crown may be cemented in the normal way. Again, the uptake of photosensitiser may be enhanced by prior treatment of the preparation with the chemicals quoted earlier.
  • PDT and the novel resin may be used to treat recurrent decay beneath restorations.
  • access is gained by cutting a tunnel cavity from the surface of the tooth to the lesion. This may be carried out using conventional instrumentation such as a small round bur (0.8mm diameter).
  • the photosensitiser is injected down the tunnel preparation into the carious lesion. Exposure time is in the range of 20 to 90 seconds. Following exposure to the photosensitiser, the isotropic probe is introduced down the tunnel preparation. The site is irradiated with hght of the appropriate wavelength for a range of times between 20 and 90 seconds. The exposure times are in the range of 20 to 60 seconds using a 40 to 150 mW power density.
  • the uptake and penetration of the photosensitiser may be enhanced by the prior use of chemicals, which will demineralise the dentine and rehydrate the collagen.
  • the novel resin may then be syringed down the access tunnel and polymerised in situ, either by the use of hght of the appropriate wavelength, or by auto-polymerisation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dentistry (AREA)
  • Biophysics (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne un procédé permettant de traiter les caries dentaires. Ce procédé consiste à accéder à la lésion carieuse, à mettre cette lésion en contact avec un photosensibilisant, à activer ce photosensibilisant en exposant la lésion à la lumière d'une longueur d'onde qui est absorbée par le photosensibilisant à l'aide d'une fibre optique qui permet d'illuminer la zone de la lésion de façon à tuer les bactéries présentes dans cette zone, et à placer une composition polymérisable pour produit d'obturation, et à faire en sorte que ladite composition guérisse.
EP00925455A 1999-04-16 2000-04-14 Appareil permettant de traiter les caries dentaires Expired - Lifetime EP1171053B1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9908824 1999-04-16
GBGB9908824.7A GB9908824D0 (en) 1999-04-16 1999-04-16 Method and apparatus for treating dental caries
GB0000886 2000-01-14
GB0000884 2000-01-14
GB0000884A GB0000884D0 (en) 2000-01-14 2000-01-14 Method and apparatus for treating dental caries
GB0000886A GB0000886D0 (en) 2000-01-14 2000-01-14 Polymerisable resin compositions for use in dentistry
PCT/GB2000/001433 WO2000062701A2 (fr) 1999-04-16 2000-04-14 Procede et appareil permettant de traiter les caries dentaires

Publications (2)

Publication Number Publication Date
EP1171053A2 true EP1171053A2 (fr) 2002-01-16
EP1171053B1 EP1171053B1 (fr) 2007-01-17

Family

ID=27255475

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00925455A Expired - Lifetime EP1171053B1 (fr) 1999-04-16 2000-04-14 Appareil permettant de traiter les caries dentaires

Country Status (12)

Country Link
EP (1) EP1171053B1 (fr)
JP (1) JP2002541907A (fr)
KR (1) KR100755529B1 (fr)
CN (1) CN100361638C (fr)
AU (1) AU773944B2 (fr)
BR (1) BR0009813A (fr)
CA (1) CA2365342C (fr)
DE (1) DE60033020T2 (fr)
DK (1) DK1171053T3 (fr)
MX (1) MXPA01010476A (fr)
NZ (1) NZ515203A (fr)
WO (1) WO2000062701A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000074587A1 (fr) * 1999-06-04 2000-12-14 Denfotex Ltd. Technique de colmatage du canal radiculaire et dispositif correspondant
US7166652B2 (en) 2000-01-14 2007-01-23 Denfotex Ltd. Polymerisable resin compositions for use in dentistry
GB0311950D0 (en) 2003-05-23 2003-06-25 Denfotex Ltd Photo-activated disinfection
US20050053895A1 (en) 2003-09-09 2005-03-10 The Procter & Gamble Company Attention: Chief Patent Counsel Illuminated electric toothbrushes emitting high luminous intensity toothbrush
AU2004279443A1 (en) * 2003-10-08 2005-04-21 Nomir Medical Technologies, Inc. Use of secondary optical emission as a novel biofilm targeting technology
DK1737492T3 (da) * 2004-04-16 2013-03-11 Bredent Medical Gmbh & Co Kg Præparat til fotodynamisk bekæmpelse af mikroorganismer samt anvendelse af præparatet
DE102008047640B4 (de) * 2008-09-17 2012-10-25 Anton Kasenbacher Verwendung eines Laserbearbeitungsgeräts zur Ablation von Zahnmaterial
DE102008053964A1 (de) * 2008-10-30 2010-05-06 Kasenbacher, Anton, Dr. Verfahren zur Bearbeitung von Gewebe und Laserbearbeitungsgerät zur Bearbeitung von Gewebe
DE102009005194B4 (de) * 2009-01-20 2016-09-08 Anton Kasenbacher Laserbearbeitungsgerät zur Bearbeitung eines Materials
JP2010207465A (ja) * 2009-03-11 2010-09-24 Osada Res Inst Ltd 口腔内スコープ
DE102010006035A1 (de) * 2010-01-27 2011-07-28 Paterok, Peter, Dr., 41061 Applicator zur Anwendung bei der photodynamischen Therapie
FR2986980B1 (fr) 2012-02-17 2021-08-27 Valois Sas Distributeur de produit fluide sur la peau ayant une source lumineuse.
CN109549734A (zh) * 2018-10-29 2019-04-02 同济大学 一种基于光固化流体树脂的小鼠牙周炎建模方法
CN110917502B (zh) * 2019-11-14 2021-11-30 中山大学 一种可促进牙组织修复的口腔植入式无线供电发光微装置
CN113616368B (zh) * 2021-08-11 2022-08-12 牡丹江医学院 一种牙齿探查装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0356868A3 (fr) 1988-09-01 1991-03-20 Dentsply International, Inc. Méthode pour le traitement des dents avec une composition adhésive pour la base de la cavité dentaire
JPH0627047B2 (ja) 1988-12-16 1994-04-13 而至歯科工業株式会社 歯科用グラスアイオノマーセメント組成物
US5073402A (en) 1989-03-16 1991-12-17 Medical Laser Technologies Limited Of Research Park Method of making an optical device
US5172763A (en) 1991-08-30 1992-12-22 Union Oil Company Of California Steam-foam drive
GB2261672A (en) 1991-11-18 1993-05-26 Michael Braden The use of biomaterials for tissue repair
WO1993021992A1 (fr) 1992-04-30 1993-11-11 Institute Of Dental Surgery Traitement au laser
US5503559A (en) * 1993-09-30 1996-04-02 Cedars-Sinai Medical Center Fiber-optic endodontic apparatus and method
DE19625975C2 (de) 1996-06-28 2003-06-12 Wolfgang Doerken Zahnmedizinisches Implantat, Schablone zum Einsetzen eines zahnmedizinischen Implantats und Verfahren zum Herstellen von diesen
CA2216053C (fr) * 1996-09-20 2007-06-26 Kuraray Co., Ltd. Methode de polymerisation d'une composition photopolymerisable a usage dentaire et appareil de photopolymerisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0062701A2 *

Also Published As

Publication number Publication date
KR100755529B1 (ko) 2007-09-06
EP1171053B1 (fr) 2007-01-17
BR0009813A (pt) 2002-04-16
DK1171053T3 (da) 2007-05-21
DE60033020T2 (de) 2007-08-30
CA2365342A1 (fr) 2000-10-26
CN100361638C (zh) 2008-01-16
MXPA01010476A (es) 2003-08-20
CN1350444A (zh) 2002-05-22
KR20020012544A (ko) 2002-02-16
WO2000062701A2 (fr) 2000-10-26
AU4418000A (en) 2000-11-02
CA2365342C (fr) 2010-08-03
AU773944B2 (en) 2004-06-10
DE60033020D1 (de) 2007-03-08
NZ515203A (en) 2004-02-27
WO2000062701A3 (fr) 2001-03-01
JP2002541907A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
CA2376093C (fr) Technique de colmatage du canal radiculaire et dispositif correspondant
EP1171053B1 (fr) Appareil permettant de traiter les caries dentaires
Cernavin et al. Laser applications in dentistry: a review of the literature
EP1819360A1 (fr) Methode de traitement photodynamique des micro-organismes dans la cavite buccale mettant en oeuvre une source de lumiere non coherente
US20060093561A1 (en) Method of treating microorganisms in the oral cavity
Sulieman An overview of the use of lasers in general dental practice: 2. Laser wavelengths, soft and hard tissue clinical applications
Hashem et al. Effectiveness of photodynamic therapy on bonding strength and failure modes of fiber-posts in c-shaped treated root canals
CN217697672U (zh) 一种用于根管灭菌消毒或美白的装置
de Paula Eduardo et al. The use of lasers for endodontic applicationsin dentistry
CN114796885A (zh) 一种用于根管灭菌消毒或美白的装置和方法
Stănuşi et al. Endodontic bacterial reduction using Diode LASER radiation–short literature review
George et al. Laser-assisted endodontics
Karlović et al. Effectiveness of Er: Yag Laser in Cavity Preparation ior Retrograde Filling–In Vitro Study
Vasishta et al. Lasers in Endodontics-A Review of Literature.
Parker Laser/Light Application in Dental Procedures
KR100756090B1 (ko) 치근관의 충전방법 및 장치
US20210353754A1 (en) Pigment for antimicrobial photodynamic therapy
Pulga Association of oxygen-ozone therapy with high-power photodynamic therapy: a new protocol for the treatment of periodontopathies
Dostálová et al. Lasers in dentistry
Syam et al. LANAP–A ray of hope in periodontal therapy
George et al. Laser-Assisted Endodontics
Stabholz et al. Lasers in endodontics.
Nagpal et al. Lasers In Endodontics-A Review.
George et al. Lasers in dentistry
Oliveira et al. Laser surface engineering in dentistry

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011031

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20040923

RTI1 Title (correction)

Free format text: APPARATUS FOR TREATING DENTAL CARIES

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070117

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070117

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60033020

Country of ref document: DE

Date of ref document: 20070308

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070428

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: ISLER & PEDRAZZINI AG

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070618

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: ISLER & PEDRAZZINI AG;POSTFACH 1772;8027 ZUERICH (CH)

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20071018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070117

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070907

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070418

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070117

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070117

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070414

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20100426

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20100428

Year of fee payment: 11

Ref country code: GB

Payment date: 20100426

Year of fee payment: 11

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20111031

Year of fee payment: 12

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110414

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20120414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120414

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20121018

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20121025

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20121018

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110415

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20130423

Year of fee payment: 14

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120430

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 60033020

Country of ref document: DE

Owner name: DENFOTEX RESEARCH LTD., GB

Free format text: FORMER OWNER: DENFOTEX LTD., CRAWLEY DOWN, GB

Effective date: 20131121

Ref country code: DE

Ref legal event code: R082

Ref document number: 60033020

Country of ref document: DE

Representative=s name: VON KREISLER SELTING WERNER, DE

Effective date: 20131121

Ref country code: DE

Ref legal event code: R082

Ref document number: 60033020

Country of ref document: DE

Representative=s name: VON KREISLER SELTING WERNER - PARTNERSCHAFT VO, DE

Effective date: 20131121

Ref country code: DE

Ref legal event code: R081

Ref document number: 60033020

Country of ref document: DE

Owner name: DENFOTEX RESEARCH LTD., GB

Free format text: FORMER OWNER: DENFOTEX LTD., CRAWLEY DOWN, WEST SUSSEX, GB

Effective date: 20131121

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130430

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130414

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60033020

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 351608

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141101

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60033020

Country of ref document: DE

Effective date: 20141101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140414